Valye reports for unlimited access

Agilysys Inc develops and delivers software and technology solutions primarily for the hospitality industry, including hotels and gaming sectors. The company operates globally with offices in North America, Europe, Asia, and the Middle East. Its business model centers on continuous product development, including cloud-based and on-premise solutions, with significant investment in research and development to maintain competitiveness. Agilysys integrates artificial intelligence and machine learning technologies both internally and in customer-facing products, while managing associated risks. The company’s revenue streams include subscription-based services and software sales, supported by service level agreements. Agilysys faces competition from established and emerging technology providers and is sensitive to macroeconomic factors affecting the hospitality sector. The company’s operations are concentrated in its Alpharetta headquarters and India R&D center, with disaster recovery plans in place. Financially, Agilysys reported net income of $38.8 million and maintains liquidity with a current ratio of 1.47 as of March 31, 2026.

LiveRamp Holdings, Inc. operates a single data collaboration platform that acts as a hub for businesses to securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics. The platform offers four core capabilities: Live/Identity for identity resolution, Live/Access for third-party data marketplace access, Live/Connectivity for data onboarding and integrations, and Live/Insights for advanced measurement and analytics using clean room technology. The company serves a global customer base including major brands, agencies, marketing technology providers, publishers, and data sellers across multiple industries. Revenue is primarily subscription-based, supplemented by revenue-sharing and transactional fees. The company reported $812.9 million in revenue for fiscal 2026, with a net income of $146.0 million and maintains strong liquidity. LiveRamp is pending acquisition by Publicis Groupe S.A. [S1]

Advanced Drainage Systems, Inc. specializes in manufacturing innovative water management products for stormwater and onsite wastewater applications. The company serves construction, agriculture, and infrastructure markets primarily in the U.S., Canada, Mexico, and South America. Its product portfolio includes high-performance thermoplastic corrugated pipe, plastic leachfield chambers, wastewater tanks, fittings, stormwater filters, and water separators. The company operates two reportable segments: Stormwater, which includes the recently acquired NDS product line expanding retail and distributor channels, and Wastewater, focused on residential wastewater treatment systems. Sales are primarily through a diversified distributor network and major retailers. The company manages logistics with an in-house fleet and targets efficient delivery lead times. Fiscal 2026 results showed growth in net sales, gross profit, and Adjusted EBITDA, with a slight decline in net income. The business is cyclical and sensitive to economic conditions, raw material costs, and seasonality. Capital expenditures support capacity expansion and technology improvements. The company maintains a strong liquidity position and manages debt with a leverage ratio of 1.6. Risks include manufacturing disruptions, supply chain challenges, product liability, and indebtedness.

Gen Digital Inc. operates as a global leader in consumer Cyber Safety and Trust-Based Solutions, providing technology products and services that protect and empower consumers' digital and financial lives. Its portfolio includes cybersecurity, online privacy, identity protection, digital reputation management, and financial wellness solutions. The company serves nearly 500 million users globally, with approximately 79 million paid customers. Gen's offerings are delivered through multiple channels including direct-to-consumer e-commerce, mobile applications, strategic partner networks, and freemium models. The company leverages AI and a unified data platform to enhance threat detection, personalize customer experiences, and build a trust layer for the emerging AI economy. Key brands include Norton, Avast, LifeLock, and MoneyLion, the latter acquired to expand financial wellness capabilities. Gen's strategy emphasizes AI-driven innovation, customer base growth, cross-selling, and platform scaling to create compounding network effects. The company maintains significant liquidity and invests in research and development to address evolving cyber threats and financial needs.

AIR Global PLC was incorporated in Jersey on October 28, 2025, initially as a private limited company before converting to a public limited company to facilitate a business combination transaction. The company’s principal executive office is in Dubai, United Arab Emirates. AIR Global PLC is the parent company of AIR and its subsidiaries, which operate as a leading global producer of branded flavored molasses products commonly known as hookah, shisha, or mu’assel. AIR’s products are distributed through direct-to-consumer, distributor, and licensed retail channels across more than 90 markets worldwide. The company’s portfolio includes well-known molasses brands such as Al Fakher, Shisha Kartel, Zødiac, NameLess, and Kloud King, alongside innovation-driven inhalation devices like OOKA and VANT. AIR Global PLC’s shares commenced trading on the Nasdaq Stock Market under the symbol AIIR in May 2026. The company is subject to certain Exchange Act filing requirements as a foreign private issuer and files annual reports on Form 20-F with audited financial statements. PricewaterhouseCoopers Limited Partnership Dubai Branch serves as the company’s independent registered public accounting firm.

INNOVATE Corp. is a publicly listed company on the NYSE under the ticker VATE. The company reported $364.8 million in revenue and a net loss of $16.8 million for the quarter ended March 31, 2026. It holds significant cash and current assets but faces liquidity challenges with a current ratio of 0.4. The company has a portfolio company, DBM Global, which has recently paid cash dividends. INNOVATE has also completed refinancing transactions to extend debt maturities and has received FDA approval for a medical device related to kidney function assessment. Recent earnings calls and market activity indicate ongoing operational developments and investor interest.

Calidi Biotherapeutics, Inc. operates as a single segment biotechnology company focused on research, development, and commercialization of oncolytic virus therapies and cancer immunotherapy products. The company’s product candidates require extensive preclinical and clinical testing and regulatory approval before commercialization. Calidi has not yet generated revenues from commercial products and has a history of net losses and negative cash flows. The company manages its operations with a focus on advancing its clinical pipeline, including programs such as CLD-101 for recurrent glioma and CLD-201 for solid tumors. Calidi has formed partnerships to facilitate clinical trial activities and regulatory submissions. The company is classified as an emerging growth company and smaller reporting company, which affords certain regulatory reporting exemptions. As of March 31, 2026, Calidi reported $9.6 million in cash and equivalents and a current ratio of 1.92, reflecting liquidity to support ongoing operations.

ARC Group Acquisition I Corp. is a special purpose acquisition company incorporated in the British Virgin Islands. It completed its IPO on May 1, 2026, issuing units consisting of ordinary shares, rights, and warrants. The company raised gross proceeds of approximately $120.75 million, which are held in a trust account pending the completion of an initial business combination. The company is classified as an emerging growth company and is subject to a 12 to 15 month deadline to complete a business combination or redeem public shares. Financial disclosures indicate a small net loss and no reported revenue as of the latest quarter ending March 31, 2026. The company’s management team includes a CEO and several directors who have entered into indemnity and administrative agreements related to the IPO.

Cibus, Inc. develops gene-edited plant traits using its proprietary RTDS® platform, enabling rapid and precise editing of elite seed genetics to improve crop productivity, sustainability, and profitability. The company’s primary business model is licensing these traits to seed companies for royalties based on seed sales. Initial focus is on herbicide tolerance traits in Rice, with additional programs in Canola, Soybean, and sustainable ingredients such as biofragrances. Cibus operates in a global seed market with an estimated $12 billion aggregate trait value. Its gene-edited traits are non-transgenic and have received favorable regulatory treatment in multiple jurisdictions, including the US, Latin America, and parts of Asia, facilitating market access. The company has completed successful greenhouse and field trials for key traits and is pursuing partner-funded projects for additional traits. Recent regulatory progress includes USDA-APHIS approvals and EU legislative advances on New Genomic Techniques. Cibus has undertaken workforce reductions and operational streamlining to conserve capital and focus on commercial advancement of priority traits. The company reported Q1 2026 revenue of $1.68 million and a net loss of $21.2 million, with $30.3 million in cash and a current ratio of 2.37 as of March 31, 2026. Cibus completed follow-on public offerings in early 2026 to raise capital and announced a merger with Calyxt in 2023.

Leafbuyer Technologies, Inc. is a technology company providing a comprehensive marketing platform for the legalized cannabis industry. The platform enables dispensaries and cannabis product companies to acquire and retain customers through tools such as SMS/MMS texting, loyalty programs, push notifications, and a custom branded application. Leafbuyer.com offers a searchable database of cannabis deals and menu items, allowing consumers to receive alerts and place orders for pickup or delivery. The company operates in 26 legal cannabis states and maintains partnerships with major cannabis POS providers. Leafbuyer’s business model leverages the expanding legalization of cannabis by entering new markets with minimal marginal cost, focusing on marketing and technology services rather than cannabis production or retail operations. The company has implemented cybersecurity risk management and reports no material legal proceedings. Financially, Leafbuyer reported $3.1 million in revenue for the nine months ended March 31, 2026, with a net income of $14,796, but has a working capital deficit and an accumulated deficit of $24.9 million [S1][S2].

Blaize Holdings, Inc. operates in the AI semiconductor industry, focusing on the development, marketing, and sale of AI chips and related software solutions. The company’s product portfolio includes proprietary AI chips and software platforms, alongside third-party hardware products. Blaize has strategic partnerships with automotive OEMs and Tier-1 suppliers for the development of automotive-grade AI chips intended for Advanced Driving Assistance Systems (ADAS), with production anticipated in 2028 or later. The company’s revenue mix currently includes a substantial portion from third-party hardware sales, which generally carry lower gross margins compared to its branded products. Blaize relies on third-party manufacturers such as Samsung Foundry and Plexus for chip fabrication and assembly, exposing it to supply chain and geopolitical risks. The company’s customer base is concentrated, with a few customers accounting for the majority of revenue and accounts receivable. Blaize has a committed equity facility to support its capital needs and continues to invest in product development and market expansion.

374Water Inc. develops and commercializes AirSCWO (supercritical water oxidation) technology aimed at advanced waste destruction and environmental remediation, particularly targeting PFAS contamination. The company operates with a leadership team experienced in technology, operations, and finance, and maintains a board with independent directors providing governance oversight. Its technology has been deployed in Department of Defense projects and partnerships with sanitation districts, reflecting application in government and municipal sectors. Financial disclosures indicate modest revenue generation with ongoing net losses and a solid liquidity position as of Q1 2026. The company supports regulatory efforts by the EPA to address PFAS contamination and is actively commercializing its technology through strategic initiatives and executive appointments.

CapsoVision, Inc develops and commercializes ingestible capsule endoscopy products for diagnosing abnormalities in the gastrointestinal tract. Its flagship product, CapsoCam Plus, is a single-use capsule endoscope with a 360° panoramic view that captures video images of the small bowel mucosa. The company also offers associated software platforms, CapsoCloud and CapsoView, enabling remote and local video review. CapsoCam Plus has FDA clearance for adult and pediatric use and telemedicine remote ingestion. The company is developing AI-assisted pathology detection technology integrated into CapsoCam Plus and a next-generation colon capsule endoscope, CapsoCam Colon, which incorporates AI for polyp detection and 3D sensing for polyp size measurement. CapsoVision sells primarily through a U.S. direct sales team and international distributors. Manufacturing relies on single-source suppliers in Taiwan and Japan, with assembly completed in the U.S. The company has a portfolio of over 140 patents and invests in R&D to enhance its products and expand indications, including early pancreatic cancer detection and esophageal varices screening. Financially, CapsoVision has a history of net losses and raised $14 million in a private placement in March 2026. It faces risks including regulatory approval delays, supply chain dependencies, competitive pressures, and the need for additional financing to support growth and clinical development.

Falcon's Beyond Global, Inc. operates in the experiential entertainment sector, providing services such as master planning, attraction design, content production, and software development. The company generates revenue through multiple streams including attraction services, shared services, destination operations, and product sales. It holds equity method investments in joint ventures that contribute to its financial results. The company has experienced significant revenue growth in 2025, driven by new contracts and strategic initiatives. It has also undergone trading halts and resumptions, reflecting stock volatility. Financial disclosures indicate a net income position in early 2026 but liquidity constraints with current liabilities exceeding current assets.

Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies and diagnostic tools for liver diseases, including non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. The company has in-licensed novel biomarker assays for early detection of liver cancer and is advancing clinical trials for its therapeutic candidates. Hepion has undergone leadership changes and capital raises to support its development pipeline. The company transitioned from Nasdaq to OTC Markets in 2025 following a delisting notice. Its business model includes drug development, diagnostic commercialization partnerships, and intellectual property licensing.

Health In Tech, Inc. is an AI-powered insurance technology platform company that offers a health insurance marketplace designed to improve processes in the healthcare industry through vertical integration, process simplification, automation, and digitalization. The platform enables insurance companies to list stop-loss policy options for self-funded benefits plans, while licensed brokers can upload required information, select plans, obtain bindable quotes typically within two minutes, and sell to businesses. HIT's subsidiaries include Stone Mountain Risk (SMR), which designs and manages self-funded benefits plans; International Captive Exchange (ICE), an MGU providing underwriting and administrative functions with a sophisticated AI-backed quoting platform; and HI Card, a platform aggregating health data and providing Medicare-based pricing through the HI Performance Network. The company targets small to large employers, focusing on making self-funded benefits plans accessible and cost-effective, especially for low-risk employers with healthy employees. As of December 31, 2025, HIT had clients in 40 states, with 583 brokers, 12 TPAs, and 263 third-party agencies registered on its platforms, serving 795 business clients with 22,515 employees. HIT reported total revenues of approximately $33.3 million for fiscal 2025 and $8.77 million for Q1 2026, with a net loss of $1.59 million in Q1 2026. The company emphasizes transparency, accessibility, and cost savings for small and mid-sized businesses underserved by traditional insurance offerings.

Thermon Group Holdings, Inc. is one of the largest providers of highly engineered industrial process heating solutions globally, serving a broad range of industries including general industrial, chemical and petrochemical, oil and gas, power generation, commercial, food and beverage, rail and transit, among others. The company offers a comprehensive suite of products such as heating units, boilers, heating cables, industrial heating blankets, temporary power solutions, and tubing bundles, complemented by engineering, installation, maintenance services, and advanced software for design optimization and control. Thermon operates through a global network of sales professionals and distributors in over 30 countries and maintains 11 manufacturing facilities across two continents. The company emphasizes technology leadership, product quality, and sustainability, with a diversified revenue base and a strategic focus on expanding non-oil-and-gas markets. Thermon's business model includes both point in time product sales and over time project-based revenues, supported by a significant backlog of signed orders. The company is currently pursuing a merger with CECO Environmental Corp., which aims to create a global leader in environmental and thermal solutions.

Kensington Capital Acquisition Corp. VI is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands on December 4, 2025. The company’s purpose is to identify and complete a business combination with one or more target businesses. It completed its initial public offering on March 5, 2026, issuing 23 million units at $10 per unit, raising gross proceeds of $230 million. Each unit includes one Class A ordinary share and warrants exercisable for additional shares. The company has not commenced operations and does not generate operating revenues. Its assets primarily consist of cash and marketable securities held in a trust account, which are intended to be used for the business combination. The company incurs general and administrative expenses and reports net losses related to these costs and changes in fair value of derivative liabilities. It has working capital loans from related parties to finance transaction costs. The company is an emerging growth company and is subject to risks typical of early-stage blank check companies.

Comstock Holding Companies, Inc. is a real estate services company specializing in asset management, property management, development, and operation of mixed-use and transit-oriented properties primarily in the Washington, D.C. metropolitan area. Since 1985, Comstock has developed and managed millions of square feet of residential, commercial, and mixed-use properties. The company’s flagship developments, Reston Station and Loudoun Station, are among the largest mixed-use, transit-oriented neighborhoods in the region. Comstock’s business model centers on long-term asset and property management agreements that provide recurring, fee-based revenue streams. The company operates through three wholly owned subsidiaries for property management: CHCI Commercial, CHCI Residential, and ParkX Management, which also provides parking and security services. The managed portfolio as of March 31, 2026, includes 100 assets comprising commercial office buildings, residential units, hospitality properties, and parking garages. Comstock maintains an asset-light, debt-free balance sheet, enabling flexibility to pursue growth opportunities. The company’s client base includes institutional investors, family offices, financial institutions, and governmental bodies. Recent financial results show revenue growth driven by expansion of the managed portfolio and increased fee-based services.

Innventure, Inc. is a Delaware-based industrial growth conglomerate that specializes in founding, funding, and operating companies that commercialize disruptive and sustainable technology solutions. These technologies are typically sourced or licensed from multinational corporations (MNCs) or other technology innovators. The company employs a proprietary DownSelect process to rigorously evaluate opportunities across multiple dimensions including disruptive potential, market need, sustainability impact, and financial returns. Innventure operates its subsidiaries through a shared services model and maintains controlling stakes in several companies such as AeroFlexx, Accelsius, and Refinity. The business model emphasizes long-term ownership and operational control to maximize value rather than pursuing early exits. The company reported a net loss in Q1 2026 and faces liquidity challenges that raise substantial doubt about its ability to continue as a going concern [S1][S2].

Stellar V Capital Corp. is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in July 2024. Its business model is to raise capital through an IPO and private placement to acquire or merge with an existing business. The company completed its IPO in January 2025, raising $150 million, with proceeds held in a trust account invested in low-risk securities. The company has not yet identified or engaged with any business combination targets. The management team has experience in SPAC transactions, capital markets, and public company operations. The company’s strategy is to target businesses with leading industry positions, sustainable competitive advantages, stable free cash flow, and growth potential. The company has a 21-month deadline from the IPO to complete a business combination or else it must liquidate and return funds to shareholders. The company’s governance includes a multi-class board of directors and indemnity agreements for officers and directors.

QuoteMedia, Inc. is a provider of financial data, market research, analytics, news feeds, and financial software solutions. Incorporated in 1999 and headquartered in Arizona, the company offers a broad range of products and services to financial institutions, brokerages, media portals, and individual investors. Its offerings include streaming real-time market data feeds, interactive web content and data APIs, and portfolio management systems delivered primarily via SaaS. The company emphasizes technological advancement, low latency data delivery, and custom development capabilities. QuoteMedia’s products cover a wide array of market data including equities, options, futures, commodities, currencies, mutual funds, ETFs, and indices, with global exchange coverage. The company’s client base is diverse, spanning online brokerages, banks, media companies, and public corporations. QuoteMedia operates primarily in North America, with a significant portion of revenue from Canada. The company’s financials show quarterly revenue of $5.53 million and a net loss of $620,612 for Q1 2026, with liquidity ratios indicating a working capital deficit but sufficient cash to fund near-term operations.

New Providence Acquisition Corp. III is a Special Purpose Acquisition Company (SPAC) incorporated in the Cayman Islands in December 2024. The company’s purpose is to identify and complete a business combination with one or more target businesses in any industry. It completed its IPO on April 25, 2025, issuing over 30 million units and raising approximately $301.65 million, which are held in a trust account. The company has not generated operating revenues and does not expect to do so until after consummating its initial business combination. The management team is experienced in acquisitions and is currently pursuing a business combination with Abra, including plans to re-domicile to Delaware and merge Abra as a wholly owned subsidiary. The company must complete its business combination by April 25, 2027, or liquidate and return funds to shareholders. The company’s securities are listed on Nasdaq under multiple ticker symbols representing shares, units, and warrants.

First Tracks Biotherapeutics, Inc. is a newly independent biotherapeutics company spun off from AnaptysBio, Inc. in April 2026. The company acquired assets related to the First Tracks Biotherapeutics Business, including intellectual property, laboratory equipment, and employee contracts. It maintains collaborations such as with Vanda Pharmaceuticals for the development and commercialization of imsidolimab, retaining rights to milestone payments. The company operates with support from a Transition Services Agreement with AnaptysBio to ensure continuity post-spin-off. As of the first quarter of 2026, the company reported a net loss and holds substantial cash reserves, reflecting its early-stage development status.

Elvictor Group, Inc. is a Nevada-incorporated company focused on providing crew and ship management services globally. It manages a diverse workforce of over 2,000 seafarers across bulk carriers and tankers, offering services such as recruitment, training, travel arrangements, and compliance with maritime and data privacy regulations. The company operates through wholly owned subsidiaries in Greece and Cyprus and acquired Ultra Shipmanagement, Inc. to enhance its ship management capabilities. Elvictor recognizes revenue primarily from long-term contracts and competes by leveraging its access to seafarer markets, operational flexibility, proprietary crew management platform, and public company transparency. It is subject to various regulatory frameworks and maintains a robust cybersecurity program overseen by its Board. Financially, as of Q1 2026, the company reported revenues near $1 million and net income of approximately $135,000, with liquidity ratios reflecting current liabilities exceeding current assets.

Vivakor, Inc. is a Nevada-based integrated midstream energy company providing crude oil transportation, terminaling, marketing, and remediation services primarily in the Permian, Eagle Ford, and Anadarko basins. The company operates a large independent trucking fleet, pipeline infrastructure including the Omega Gathering Pipeline, and strategically located terminaling and storage facilities supported by long-term contracts with minimum volume commitments. Its marketing and trading segment manages commodity purchases and sales, leveraging its transportation and terminaling network. The remediation segment, currently under development, focuses on processing oilfield waste to recover hydrocarbons and provide environmental solutions. Vivakor’s business model integrates these segments to capture margin across the crude oil value chain and expand service offerings. The company faces operational, financial, and market risks typical of midstream energy firms, including customer concentration, geographic concentration, regulatory changes, and liquidity constraints.

NVIDIA Corporation develops and sells accelerated computing platforms that combine high-performance GPUs, CPUs, DPUs, and networking components with a broad software stack including CUDA, AI models, and domain-specific frameworks. The company targets four primary markets: Data Center, Gaming, Professional Visualization, and Automotive. Its Data Center segment provides infrastructure for AI training and inference, scientific computing, and networking, featuring architectures such as Blackwell and Rubin. The Graphics segment offers GPUs for gaming and professional visualization, leveraging AI-enhanced rendering technologies. NVIDIA's automotive solutions include AI hardware and software platforms for autonomous and electric vehicles under the DRIVE brand. The company operates a fabless manufacturing model, relying on leading foundries and contract manufacturers. NVIDIA's customer base includes major cloud providers, AI model makers, OEMs, and system integrators. The company maintains a large developer community and invests heavily in R&D to sustain technology leadership.

KonaTel, Inc. is a telecommunications company providing cellular products and services nationwide primarily through its subsidiaries Apeiron Systems and IM Telecom. Apeiron Systems offers a suite of cloud-based communications platform services (CPaaS) including voice, messaging, and network connectivity, while IM Telecom operates as an FCC licensed Eligible Telecommunications Carrier distributing subsidized mobile voice and data services under the Lifeline and formerly the ACP programs. The company sources wireless services from major national carriers and wholesalers and distributes its services through multiple channels including direct sales and independent sales organizations. KonaTel has undergone several mergers and acquisitions to expand its service offerings and currently operates with a relatively small employee base. The company faces regulatory risks related to FCC programs, competitive pressures from larger carriers and resellers, and operational risks including supply chain and cybersecurity challenges. Financially, KonaTel reported revenues of approximately $1.9 million and a net loss for the quarter ended March 31, 2026, with liquidity ratios below 1 indicating potential short-term financial constraints.

Nordson Corporation is a diversified industrial company operating primarily in three segments: Industrial Precision Solutions (IPS), Medical and Fluid Solutions (MFS), and Advanced Technology Solutions (ATS). The company designs, manufactures, and markets precision dispensing equipment, fluid management systems, and advanced technology products serving various industries including packaging, medical, electronics, and industrial coatings. Nordson's revenue recognition is based on short-term fixed-price contracts with revenue recognized at shipment or transfer of control. The company maintains a strong liquidity position supported by cash, current assets, and a $1.2 billion revolving credit facility. Nordson actively manages risks related to cybersecurity and global trade policies. The company has a history of acquisitions, divestitures, and share repurchases, with goodwill tested annually for impairment and no impairments recorded in 2025 [S1][S2].

Aditxt, Inc. is a biotechnology company incorporated in 2017, engaged in developing innovative therapies and diagnostic technologies. Its product pipeline includes ADI-100, a therapy that has advanced to human clinical trials as of early 2026. The company also has a subsidiary, Pearsanta, which acquired patents related to early cancer detection. Aditxt has not yet achieved significant commercial revenue and operates with ongoing net losses. The company’s financial position is strained, with low liquidity ratios and substantial current liabilities. It is subject to regulatory approval processes and competitive pressures typical of the biotech sector.

Cosmos Health Inc. operates as a diversified healthcare group with a vertically integrated business model encompassing research and development, manufacturing, marketing, sales, and distribution of pharmaceutical and nutraceutical products. The company’s pharmaceutical portfolio includes generic medicines across multiple therapeutic areas, proprietary nutraceutical brands such as Sky Premium Life® and Mediterranation®, and biocides with antimicrobial properties. Manufacturing facilities are certified under European GMP and EMA standards, supporting production of a broad range of healthcare products. Distribution leverages advanced robotic technologies to ensure accuracy and efficiency. The company also offers telehealth services through its ZipDoctor platform and utilizes an AI-driven drug repurposing platform, Cloudscreen®, to identify new therapeutic applications for existing drugs. Geographically, Cosmos Health generates most revenues from the EU and UK, with expanding presence in the UAE and North America. The company pursues growth through expanding proprietary brands, optimizing generics, enhancing manufacturing capabilities, and expanding global distribution networks.

Ralph Lauren Corporation is a publicly traded company known for its apparel and lifestyle products. The company reported fiscal year 2026 financial results with revenues exceeding $8 billion and net income nearing $1 billion. It maintains strong liquidity with a current ratio above 2 and a cash ratio above 1 as of the fiscal year end. Recent quarterly results indicate positive earnings and revenue performance, supported by multiple news reports and SEC filings.

REGO Payment Architectures, Inc. is a Delaware-based company providing a mobile payment platform called Mazoola®, designed to enable minors, especially under 13, to transact and learn financial management under parental oversight. The platform is compliant with COPPA and GDPRkids™ Trustmark standards, emphasizing privacy and security. REGO targets financial institutions, FinTech firms, and other partners for licensing and white-labeling its technology. The company aims to serve digital-native generations (Gen Z and Gen Alpha) and has expanded offerings to include elder financial management tools. Revenue streams include subscriptions, transaction fees, licensing, data analytics, and advertising. As of Q1 2026, the company has limited revenue and significant net losses, with a small employee base and outsourced development and marketing.

TruGolf Holdings, Inc. is a virtual golf technology company headquartered in Utah, USA. It develops and markets golf simulation products and services, including hardware and software solutions for golf enthusiasts and commercial operators. The company operates a franchising model under the TruGolf Links brand and has expanded its footprint with new franchise locations. TruGolf integrates advanced technologies such as AI to enhance its product offerings, exemplified by its acquisition of AI firm mlSpatial and the introduction of AI coaching features. The leadership team has deep experience in gaming and technology sectors, supporting the company's innovation and growth strategies.

Greenway Technologies, Inc. develops proprietary GTL synthesis gas conversion systems and modular micro-plants scalable to meet specific gas field production needs. Its patented G-Reformer unit converts various natural gas streams into syngas, which is then processed via Fischer-Tropsch reactors to produce cleaner fuels such as gasoline, diesel, jet fuel, methanol, and high-value chemicals. The company aims to commercialize and license this technology primarily in the U.S. market. The technology enables smaller, transportable GTL plants with lower costs and footprints compared to traditional large-scale refinery plants. Greenway holds multiple patents and has an exclusive licensing agreement with the University of Texas at Arlington. The company is in the development stage with no current revenues and faces liquidity and going concern challenges.

ASP Isotopes Inc. is a publicly traded company on Nasdaq (ASPI) headquartered in Dallas, Texas. The company focuses on the production of helium and the development of advanced nuclear fuels through its subsidiary Quantum Leap Energy LLC. ASP Isotopes completed the acquisition of Renergen Limited, a helium project operator, with strong shareholder approval. The company has raised capital through multiple registered direct offerings to support its growth initiatives. The leadership team includes founder and CEO Paul E. Mann, who has extensive experience in healthcare and chemicals investment. The board of directors includes members with significant expertise in nuclear energy, finance, and strategic governance. Financially, ASP Isotopes reported Q1 2026 revenue of $4.18 million and a net loss of $7.12 million, with a strong liquidity position and a current ratio of 4.39, indicating solid short-term financial health.